Reaktionsgleichung
[CH2:1]([OH:14])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH:11]([CH3:13])[CH3:12].[CH:15]1[CH:16]=[CH:17][C:18]2S(=O)(=O)[O:22][C:21]([C:33]3[CH:34]=[CH:35][C:36](O)=[CH:37][CH:38]=3)([C:26]3[CH:27]=[CH:28][C:29](O)=[CH:30][CH:31]=3)[C:19]=2[CH:20]=1>>[C:1]([O:14][CH2:1][CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH:11]([CH3:12])[CH3:13])(=[O:14])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:38][CH2:37][CH2:36]/[CH:35]=[CH:34]\[CH2:33]/[CH:21]=[CH:26]\[CH2:27][CH2:28][CH2:29][CH2:30][CH3:31].[C:21]([O:14][CH2:1][CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH:11]([CH3:12])[CH3:13])(=[O:22])[C:19]1[CH:20]=[CH:15][CH:16]=[CH:17][CH:18]=1Komponenten
4
Versuchsvorschrift
The sebocyte assay procedure described in Example 2 was repeated with additional branched esters. The results that were obtained are summarized in Table 4. Isotridecyl linoleate and isotridecyl benzoate were synthesised according to the procedure of Example 1, using Exxal® 13 isotridecanol as starting material. The results that were obtained are summarized in Table 5. Phenol Red was used as a positive control.
Aufarbeitung
- customThe results that
- customwere obtained
- customThe results that
- customwere obtained
Quellen und Nachweise
- ORD-Eintrag
- ord-05f803e6aa034628bca47ea8ec98f0cf
- Quelldatensatz
- uspto-grants-2003_07
- Patentnummer
- US06599936B1
Verknüpfte Notizen
Wird geladen…